SignatureFD’s Revolution Medicines RVMD Stock Holding History

SignatureFD’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100	Closed	-$5.25K	–	3611
2026 Q1	$5.25K	Buy	+100	New	+$10.1K	﹤0.01%	2763

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

SignatureFD's RVMD Position: Q2 2026 in Review

SignatureFD increased its Revolution Medicines (RVMD) stake by 71% in Q2 2026, buying an estimated $98.6K and bringing the position to 1,625 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #892.

SignatureFD first reported a position in RVMD in Q3 2021 and has held it in 19 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

SignatureFD held 1,625 shares of Revolution Medicines worth $304K as of Q2 2026.
SignatureFD bought 675 Revolution Medicines shares in Q2 2026, an estimated $98.6K.
Revolution Medicines made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #892 holding.
SignatureFD first reported a position in Revolution Medicines in Q3 2021 and has held it in 19 quarters since.
693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.